Traws PharmaTRAW
TRAW
$0.3420
2.2%
Market Cap: $8.66M
About: Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.
Employees: 17
0
Funds holding %
of 6,710 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
16% more funds holding
Funds holding: 25 [Q1] → 29 (+4) [Q2]
3.15% more ownership
Funds ownership: 8.25% [Q1] → 11.4% (+3.15%) [Q2]
26% less capital invested
Capital invested by funds: $1.75M [Q1] → $1.29M (-$461K) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for TRAW.